skip to content
Thank you for visiting First Coast Service Options' Medicare provider website. This website is intended exclusively for Medicare providers and health care industry professionals to find the latest Medicare news and information affecting the provider community.
To enable us to present you with customized content that focuses on your area of interest, please select your preferences below:
Select which best describes you:
Select your location:
Select your line of business:

By clicking Continue below you agree to the following:

LICENSE FOR USE OF "PHYSICIAN'S CURRENT PROCEDURAL TERMINOLOGY" (CPT), FOURTH EDITION End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2022 American Medical Association (AMA).

All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.
You, your employees, and agents are authorized to use CPT only as contained in the following authorized materials:
Local Coverage Determinations (LCDs),
Local Medical Review Policies (LMRPs),
Bulletins/Newsletters,
Program Memoranda and Billing Instructions,
Coverage and Coding Policies,
Program Integrity Bulletins and Information,
Educational/Training Materials,
Special mailings,
Fee Schedules;

internally within your organization within the United States for the sole use by yourself, employees and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare and Medicaid Services (CMS), formerly known as Health Care Financing Administration (HCFA). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website. Applicable FARS/DFARS restrictions apply to government use.

AMA Disclaimer of Warranties and Liabilities CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this agreement.

CMS Disclaimer: The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

AMA - U.S. Government Rights

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a )June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

ADA CURRENT DENTAL TERMINOLOGY, (CDT)
End User/Point and Click Agreement: These materials contain Current Dental Terminology (CDTTM), Copyright © 2016 American Dental Association (ADA). All rights reserved. CDT is a trademark of the ADA.

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING ON THE BUTTON LABELED "ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK ON THE BUTTON LABELED "DECLINE" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the ADA website.

Applicable Federal Acquisition Regulation Clauses (FARS)\Department of restrictions apply to Government Use.

ADA DISCLAIMER OF WARRANTIES AND LIABILITIES: CDT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third party beneficiary to this Agreement.

CMS DISCLAIMER: The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT should be addressed to the ADA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

End Disclaimer


This website provides information and news about the Medicare program for health care professionals only. All communication and issues regarding your Medicare benefits are handled directly by Medicare and not through this website. For the most comprehensive experience, we encourage you to visit Medicare.gov or call 1-800-MEDICARE. In the event your provider fails to submit your Medicare claim, please view these resources for claim assistance.
Join eNews       En Español
Text Size:
YouTube LinkedIn Email Print
Send a link to this page
[Multiple email addresses must be separated by a semicolon.]
Last Modified: 10/2/2024 Location: FL, PR, USVI Business: Part A, Part B

Radiopharmaceutical HCPCS codes no longer requiring a paper invoice (JN)

To reduce provider burden, certain contractor priced HCPCS codes no longer require a paper invoice.
When the invoice information is entered in the narrative field on a claim for any of the HCPCS codes listed below, it is not necessary to provide the actual paper invoice for these services. For details, view our article on the process for supplying invoice amount on certain HCPCS codes to avoid rejected claims.

Code
Description
Effective "from"
date of service
Effective "through"
date of service
A4642
Indium In-111 satumomab pendetide, diagnostic, per study dose up to 6 millicuries
1/1/2024
Present
A9501
Technetium Tc-99m teboroxime, diagnostic, per study dose
1/1/2024
Present
A9503
Technetium Tc-99m medronate, diagnostic, per study dose, up to 30 mCi
1/1/2024
Present
A9504
Technetium Tc-99m apcitide, diagnostic, per study dose, up to 20 mCi
1/1/2024
Present
A9507
Indium In-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
1/1/2024
Present
A9508
Iodine I-131 iobenguane sulfate, diagnostic, per 0.5 mCi
1/1/2024
Present
A9509
Iodine I-123 sodium iodide, diagnostic, per mCi
1/1/2024
Present
A9510
Technetium Tc-99m disofenin, diagnostic, per study dose, up to 15 mCi
1/1/2024
Present
A9512
Technetium Tc-99m pertechnetate, diagnostic, per mCi
1/1/2024
Present
A9516
Iodine I-123 sodium iodide, diagnostic, per 100 mcCi, up to 999 mcCi
1/1/2024
Present
A9517
Iodine I-131 sodium iodide capsule(s), therapeutic, per mCi
1/1/2024
Present
A9526
Nitrogen N-13 ammonia, diagnostic, per study dose, up to 40 mCi
1/1/2024
Present
A9527
Iodine I-125, sodium iodide solution, therapeutic, per mCi
1/1/2024
Present
A9528
Iodine I-131 sodium iodide capsule(s), diagnostic, per mCi
1/1/2024
Present
A9529
Iodine I-131 sodium iodide solution, diagnostic, per mCi
1/1/2024
Present
A9530
Iodine I-131 sodium iodide solution, therapeutic, per mCi
1/1/2024
Present
A9531
Iodine I-131 sodium iodide, diagnostic, per mcCi (up to 100 mcCi)
1/1/2024
Present
A9532
Iodine I-125 serum albumin, diagnostic, per 5 mcCi
1/1/2024
Present
A9536
Technetium Tc-99m depreotide, diagnostic, per study dose, up to 35 mCi
1/1/2024
Present
A9538
Technetium Tc-99m pyrophosphate, diagnostic, per study dose, up to 25 mCi
1/1/2024
Present
A9539
Technetium Tc-99m pentetate, diagnostic, per study dose, up to 25 mCi
1/1/2024
Present
A9540
Technetium Tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 mCi
1/1/2024
Present
A9541
Technetium Tc-99m sulfur colloid, diagnostic, per study dose, up to 20 mCi
1/1/2024
Present
A9542
Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi
1/1/2024
Present
A9546
Cobalt Co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 mcCi
1/1/2024
Present
A9550
Technetium Tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 mCi
1/1/2024
Present
A9553
Chromium Cr-51 sodium chromate, diagnostic, per study dose, up to 250 mcCi
1/1/2024
Present
A9557
Technetium Tc-99m bicisate, diagnostic, per study dose, up to 25 mCi
1/1/2024
Present
A9559
Cobalt Co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 mcCi
1/1/2024
Present
A9560
Technetium Tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 mCi
1/1/2024
Present
A9561
Technetium Tc-99m oxidronate, diagnostic, per study dose, up to 30 mCi
1/1/2024
Present
A9562
Technetium Tc-99m mertiatide, diagnostic, per study dose, up to 15 mCi
1/1/2024
Present
A9563
Sodium phosphate P-32, therapeutic, per mCi
1/1/2024
Present
A9564
Chromic phosphate P-32 suspension, therapeutic, per mCi
1/1/2024
Present
A9566
Technetium Tc-99m fanolesomab, diagnostic, per study dose, up to 25 mCi
1/1/2024
Present
A9567
Technetium Tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 mCi
1/1/2024
Present
A9569
Technetium Tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
1/1/2024
Present
A9570
Indium In-111 labeled autologous white blood cells, diagnostic, per study dose
1/1/2024
Present
A9571
Indium In-111 labeled autologous platelets, diagnostic, per study dose
1/1/2024
Present
A9572
Indium In-111 pentetreotide, diagnostic, per study dose, up to 6 mCi
1/1/2024
Present
A9580
Sodium fluoride F-18, diagnostic, per study dose, up to 30 mCi
1/1/2024
Present
A9583
Injection, gadofosveset trisodium, 1 ml
1/1/2024
Present
A9586
Florbetapir F18, diagnostic, per study dose, up to 10 mCi
1/1/2024
Present
A9590
Iodine I-131, iobenguane, 1 mCi
1/1/2024
Present
A9597
Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified
1/1/2024
Present
A9598
Positron emission tomography radiopharmaceutical, diagnostic, for nontumor identification, not otherwise classified
1/1/2024
Present
A9601
Flortaucipir F 18 injection, diagnostic, 1 mCi
1/1/2024
Present
A9602
Fluorodopa f-18, diagnostic, per mCi
1/1/2024
Present
A9603
Injection, pafolacianine, 0.1 mg
1/1/2024
Present
A9609
Fludeoxyglucose f18 up to 15 millicuries
1/1/2024
Present
A9610
Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
10/1/2024
Present
A9697
Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
1/1/2024
Present
A9698
Nonradioactive contrast imaging material, not otherwise classified, per study
1/1/2024
Present
A9700
Supply of injectable contrast material for use in echocardiography, per study
1/1/2024
Present
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.